Published Date: 24 May 2023
Today, late-breaking clinical research was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) based on results from the first-in-human trial of a novel percutaneous ventricular assist device (pVAD).
Read Full NewsFindings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation